Jasper Therapeutics Inc.
(JSPR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 13,947 | 13,747 | 12,708 | 11,963 | 12,778 |
| Operating Income | -13,947 | -13,747 | -12,708 | -11,963 | -12,778 |
| Other Income | -313 | 536 | 845 | 1,559 | 10,571 |
| Pre-tax Income | -14,260 | -13,211 | -11,863 | -10,404 | -2,207 |
| Net Income Continuous | -14,260 | -13,211 | -11,863 | -10,404 | -2,207 |
| Net Income | $-14,260 | $-13,211 | $-11,863 | $-10,404 | $-2,207 |
| EPS Basic Total Ops | -1.62 | -3.60 | -3.20 | -2.90 | -0.60 |
| EPS Basic Continuous Ops | -1.62 | -3.60 | -3.24 | -2.86 | -0.61 |
| EPS Diluted Total Ops | -1.62 | -3.60 | -3.20 | -2.90 | -0.60 |
| EPS Diluted Continuous Ops | -1.62 | -3.60 | -3.24 | -2.86 | -0.61 |
| EBITDA(a) | $-13,673 | $-13,474 | $-12,440 | $-11,745 | $-12,562 |